Advanced

Long-term follow-up of patients with ANCA-associated vasculitis

Heijl, Caroline LU (2017)
Abstract (Swedish)
Bibliographical note: Här klistrar du in följande text:
Defence details
Date: [yyyy-mm-dd]
Time: [hh:mm]
Place: [text without newline or tabs]
External reviewer(s)
Name: [surname, first name]
Title: [text without newline or tabs]
Affiliation: [text without newline or tabs]
---
ISSN: 1652-8220
Lund University, Faculty of Medicine Doctoral Dissertation Series 2017:??
Abstract
This thesis is based on long-term follow-up results from two cohorts of patients with ANCA-associated vasculitis; one cohort with 535 patients originally included in 4 European randomized clinical trials (papers I and II) and one Swedish population-based cohort including 195 patients (papers III and IV). Two areas are covered in the two cohorts, respectively; the assessment of mortality, prognostic factors and causes of death in the two cohorts (paper I and III) and the assessment of malignancy risk compared with a matched general population (papers II and IV).
Results
Paper I: 1-, 2-, and 5-year survival was 88%, 85% and 78%. Predictors of death were age, gender, kidney function and disease activity at presentation. Main causes of... (More)
This thesis is based on long-term follow-up results from two cohorts of patients with ANCA-associated vasculitis; one cohort with 535 patients originally included in 4 European randomized clinical trials (papers I and II) and one Swedish population-based cohort including 195 patients (papers III and IV). Two areas are covered in the two cohorts, respectively; the assessment of mortality, prognostic factors and causes of death in the two cohorts (paper I and III) and the assessment of malignancy risk compared with a matched general population (papers II and IV).
Results
Paper I: 1-, 2-, and 5-year survival was 88%, 85% and 78%. Predictors of death were age, gender, kidney function and disease activity at presentation. Main causes of death were active vasculitis and infection during the first year, and after the first year, malignancy and cardiovascular disease. Paper II: Higher risk for malignancy at all sites and non-melanoma skin cancer. Paper III: 1-, 2-, 5-, and 10-year survival was 87%, 82%, 70% and 55%, respectively. Predictors of death were age, gender, kidney function and organ involvement at diagnosis. Main causes of death were active vasculitis and infection during the first year, and after the first year, malignancy and cardiovascular disease. Paper IV: Higher risk for malignancy at all sites, non-melanoma skin cancer, bladder cancer and pancreatic cancer.
Conclusions: The mortality and malignancy risks in patients treated for AAV with current treatment protocols are higher than in the general population. However, the mortality in the group of patients with AAV without gastrointestinal, cardiovascular, or renal involvement at presentation is not significantly increased compared with the general population.
(Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • professor Stegmayr, Bernd, Umeå University
organization
publishing date
type
Thesis
publication status
published
subject
keywords
Anca-associated vasculitis
pages
70 pages
publisher
Lund University, Faculty of Medicine
defense location
Segerfalksalen, Biomedicinskt centrum (BMC), Sölvegatan 17, Lund.
defense date
2017-05-19 13:00
ISBN
978-91-7619-441-6
language
English
LU publication?
yes
id
93c550df-4b8a-4376-8613-f47cd2f09d8e
date added to LUP
2017-05-25 16:35:56
date last changed
2017-05-29 11:22:01
@phdthesis{93c550df-4b8a-4376-8613-f47cd2f09d8e,
  abstract     = {This thesis is based on long-term follow-up results from two cohorts of patients with ANCA-associated vasculitis; one cohort with 535 patients originally included in 4 European randomized clinical trials (papers I and II) and one Swedish population-based cohort including 195 patients (papers III and IV). Two areas are covered in the two cohorts, respectively; the assessment of mortality, prognostic factors and causes of death in the two cohorts (paper I and III) and the assessment of malignancy risk compared with a matched general population (papers II and IV).<br/>Results<br/>Paper I: 1-, 2-, and 5-year survival was 88%, 85% and 78%. Predictors of death were age, gender, kidney function and disease activity at presentation. Main causes of death were active vasculitis and infection during the first year, and after the first year, malignancy and cardiovascular disease.   Paper II: Higher risk for malignancy at all sites and non-melanoma skin cancer.                         Paper III: 1-, 2-, 5-, and 10-year survival was 87%, 82%, 70% and 55%, respectively. Predictors of death were age, gender, kidney function and organ involvement at diagnosis. Main causes of death were active vasculitis and infection during the first year, and after the first year, malignancy and cardiovascular disease. Paper IV: Higher risk for malignancy at all sites, non-melanoma skin cancer, bladder cancer and pancreatic cancer.<br/>Conclusions: The mortality and malignancy risks in patients treated for AAV with current treatment protocols are higher than in the general population. However, the mortality in the group of patients with AAV without gastrointestinal, cardiovascular, or renal involvement at presentation is not significantly increased compared with the general population.<br/>},
  author       = {Heijl, Caroline},
  isbn         = {978-91-7619-441-6},
  keyword      = {Anca-associated vasculitis},
  language     = {eng},
  pages        = {70},
  publisher    = {Lund University, Faculty of Medicine},
  school       = {Lund University},
  title        = {Long-term follow-up of patients with ANCA-associated vasculitis},
  year         = {2017},
}